Net Cash Provided by (Used in) Operating Activities |
-1.53M |
USD |
+3.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-71.3K |
USD |
-125% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-19.7K |
USD |
+85.8% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
44.1M |
shares |
+3.76% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.84M |
USD |
+213% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
2.52M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
2.98M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.56M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Authorized |
5M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Additional Paid in Capital |
36.9M |
USD |
+53.1% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Depreciation, Depletion and Amortization |
71.5K |
USD |
+48.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
455K |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
10.8K |
USD |
-74.2% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |